Live from the NIH registry
Studies recruiting near Davenport right now
Top 25 of 43 recruiting studies, sorted by proximity — each links to its official registry page
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Breast Carcinoma, Colorectal Carcinoma
N/A
Observational 2,000 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: Wake Forest University Health Sciences
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
Trinity Medical Center — Moline, Illinois (5.8 mi)
· Sponsor: National Cancer Institute (NCI)
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features
Phase 3
Interventional 600 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: National Cancer Institute (NCI)
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer
Phase 3
Interventional 590 participants sought
University of Iowa Health Care Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: Revolution Medicines, Inc.
IC-8 Apthera IOL New Enrollment Post Approval Study
Cataract, Presbyopia
N/A
Observational 435 participants sought
Virdi Eye Clinic and Laser Vision Center — Rock Island, Illinois (3.5 mi)
· Sponsor: Bausch & Lomb Incorporated
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
Phase 3
Interventional 2,000 participants sought
Research Site — Davenport, Iowa (2.7 mi)
· Sponsor: DalCor Pharmaceuticals
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
Phase 3
Interventional 228 participants sought
Trinity Medical Center — Moline, Illinois (5.8 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
FastWire REvascularisation of Extremities, (For LOWer Limbs) - FREEFLOW
Chronic Total Occlusion of Artery of the Extremities
N/A
Interventional 65 participants sought
Vascular Institute of the Midwest — Davenport, Iowa (2.7 mi)
· Sponsor: Versono Medical Ltd
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: NRG Oncology
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
Moderate Aortic Valve Stenosis
Phase 2, Phase 3
Interventional 1,276 participants sought
Cardiovascular Medicine — Moline, Illinois (5.8 mi)
· Sponsor: Kardigan, Inc.
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
Trinity Medical Center — Moline, Illinois (5.8 mi)
· Sponsor: SWOG Cancer Research Network
The THOR IDE Study
Peripheral Artery Disease, Peripheral Artery Stenosis
N/A
Interventional 155 participants sought
Vascular Institute of the Midwest — Davenport, Iowa (2.7 mi)
· Sponsor: Philips Clinical & Medical Affairs Global
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Hematopoietic and Lymphoid Cell Neoplasm, Immune System Disorder
N/A
Observational 2,240 participants sought
MercyOne Genesis Davenport Medical Center — Davenport, Iowa (2.7 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Metastatic Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8
Phase 2
Interventional 146 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma
Phase 3
Interventional 382 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,000 participants sought
Trinity Medical Center — Moline, Illinois (5.8 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: SWOG Cancer Research Network
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma
Phase 3
Interventional 1,295 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
The Fourth Left Atrial Appendage Occlusion Study
Atrial Fibrillation, Stroke, Ischemic
N/A
Interventional 4,000 participants sought
Cardiovascular Medicine, PLLC and Unity Point Trinity Rock Island — Rock Island, Illinois (3.5 mi)
· Sponsor: Hamilton Health Sciences Corporation
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma
Phase 3
Interventional 1,210 participants sought
MercyOne Genesis Davenport Medical Center — Davenport, Iowa (2.7 mi)
· Sponsor: National Cancer Institute (NCI)
EVERO Drug-coated Balloon (DCB) Randomized Trial
Peripheral Vascular Disease, Peripheral Arterial Disease
N/A
Interventional 410 participants sought
Midwest Cardiovascular Research Foundation — Davenport, Iowa (2.7 mi)
· Sponsor: Cook Research Incorporated
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: NRG Oncology
Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes
Peripheral Arterial Disease
N/A
Observational 14,000 participants sought
Mid West Cardiovascular Research Foundation — Davenport, Iowa (2.7 mi)
· Sponsor: Baylor Research Institute
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Stage III Colon Cancer
Phase 2, Phase 3
Interventional 1,912 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: NRG Oncology
AcoArt Litos PCB Below-the-knee Global Trial
Chronic Limb-Threatening Ischemia
N/A
Interventional 288 participants sought
Midwest Cardiovascular Research Foundation — Davenport, Iowa (2.7 mi)
· Sponsor: Acotec Scientific Co., Ltd